Gabriella Björknert Caracciolo has today announced that she will leave the role as CFO and deputy CEO for Bactiguard Holding AB (publ) RegulatoryDecember 13, 2021 08:00 CET
Nomination Committee appointed for the Annual General Meeting 2022 RegulatoryOctober 29, 2021 08:00 CET
Invitation to presentation of Bactiguard’s interim report on October 28, 2021 October 25, 2021 08:00 CET
New clinical trial shows 53% reduction of ventilator-associated pneumonia with Bactiguard’s endotracheal tube October 5, 2021 08:00 CET
Bactiguard completes a directed new share issue to AMF, raising approximately SEK 228 million RegulatorySeptember 22, 2021 00:07 CET
Bactiguard-coated Zimmer Biomet trauma implants for infection prevention launched in select EMEA markets June 15, 2021 08:30 CET
Bulletin from Bactiguard Holding AB’s (publ) Annual General Meeting RegulatoryApril 28, 2021 12:00 CET
Invitation to the presentation of Bactiguard’s interim report for the first quarter and ahead of the AGM 2021 April 19, 2021 08:00 CET
Notice to attend the Annual General Meeting of Bactiguard Holding AB RegulatoryMarch 26, 2021 11:00 CET
A large randomized clinical trial shows significant reduction in urinary tract infections March 11, 2021 18:00 CET
Health Canada provides COVID-19 Interim Order approval for Bactiguard’s TempSensor catheter February 9, 2021 09:00 CET
Invitation to presentation of Bactiguard’s year-end report for 2020 on February 4, 2021 February 1, 2021 08:30 CET
Bactiguard-coated Zimmer Biomet trauma implants receive European regulatory clearance RegulatoryJanuary 21, 2021 18:30 CET
